Houston, TX, United States of America

Srishtee Arora


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Srishtee Arora: Innovator in Therapeutics and Vaccines

Introduction

Srishtee Arora is a notable inventor based in Houston, Texas. He has made significant contributions to the field of therapeutics and vaccines, particularly through his innovative research and patent work. His expertise lies in the development of compositions that utilize a fibrinogen binding motif for medical applications.

Latest Patents

Arora holds a patent for "Compositions and use of a fibrinogen binding motif present in EFB and COA for therapeutics and vaccines against." This patent outlines methods and compositions that include vaccines, monoclonal antibodies, and polyclonal antibodies. The invention focuses on a chimeric molecule of an extracellular fibrinogen binding protein (Efb) and targeted agent delivery pharmaceutical compositions. These compositions are designed to inhibit fibrinogen binding and C3 binding, thereby enhancing the effectiveness of vaccines against staphylococcus bacteria.

Career Highlights

Throughout his career, Srishtee Arora has worked with prestigious institutions, including the Texas A&M University System and Technische Universität Braunschweig. His work has been instrumental in advancing the understanding and application of fibrinogen binding proteins in therapeutic contexts.

Collaborations

Arora has collaborated with notable colleagues, including Ya-Ping Ko and Magnus A Hook. These partnerships have contributed to the development of innovative solutions in the field of medical research.

Conclusion

Srishtee Arora's contributions to the field of therapeutics and vaccines highlight his role as a leading inventor. His patent work and collaborations reflect a commitment to advancing medical science and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…